U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07944625) titled 'Clinical Trial to Evaluate the Protective Effect of Larazotide Acetate in Individuals With Well-Controlled Celiac Disease' on Nov. 10.

Brief Summary: The goal of this clinical trial is to learn if larazotide acetate, which will be tested at two doses and compared to placebo, can help prevent signs and symptoms of celiac disease in patients with well-controlled celiac disease who are following a gluten-free diet. Both adults and children (ages 12 years and up) will be allowed to enroll in this study.

Study Start Date: Feb., 2027

Study Type: INTERVENTIONAL

Condition: Celiac Disease Celiac Disease in Adolescents

Intervention: DRU...